Overview

Efficacy and Safety Study of Prucalopride to Treat Chronic Constipation

Status:
Completed
Trial end date:
1999-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether prucalopride is safe and effective in the treatment of chronic constipation. Hypothesis: Prucalopride 2 mg and 4 mg given once daily for 12 weeks is superior to placebo for the treatment of patients with chronic constipation and is well tolerated in those patients
Phase:
Phase 3
Details
Lead Sponsor:
Movetis
Treatments:
Prucalopride